Literature DB >> 1976234

Different types of opioid receptors mediating analgesia induced by morphine, DAMGO, DPDPE, DADLE and beta-endorphin in mice.

H H Suh1, L F Tseng.   

Abstract

The effects of intracerebroventricular (i.c.v.) administration of D-Phe-Cys-Tyr-D-Try-Orn-Thr-Pen-Thr-NH2 (CTOP), a selective mu-opioid receptor antagonist, (Allyl)2-Tyr-Aib-Aib-Phe-Leu-OH (ICI 174864) and (N,N-Bisallyl-Tyr-Gly-Gly-psi-(CH2S)-Phe-Leu-OH (ICI 154129), selective delta-opioid receptor antagonists on blocking analgesia induced by beta-endorphin, morphine, D-Ala2-NMePhe4-Gly-ol-enkephalin (DAMGO), D-Ala2-D-Leu5-enkephalin (DADLE) and D-Pen2-enkephalin (DPDPE) administered i.c.v. were studied in male ICR mice. The analgesia was assessed by the tail-flick and paw-licking (hot-plate) tests. The potencies of opioid agonists injected i.c.v. for producing analgesia were DAMGO greater than DADLE greater than beta-endorphin greater than morphine greater than DPDPE. Intracerebroventricular administration of CTOP (0.05 micrograms) selectively antagonized inhibition of the tail-flick and paw-licking response induced by morphine, DAMGO or DADLE but not beta-endorphin or DPDPE. ICI 174864 (5 micrograms) and ICI 154129 (5 micrograms) injected i.c.v. selectively antagonized analgesia induced by DPDPE or DADLE but not beta-endorphin, morphine or DAMGO injected i.c.v. These results indicate that analgesia induced by morphine and DAMGO is mediated by the stimulation of mu-opioid receptors while analgesia induced by DPDPE is mediated by the stimulation of delta-opioid receptors. DADLE-induced analgesia is mediated by the stimulation of both mu- and delta-opioid receptors. Analgesia induced by beta-endorphin is mediated by neither mu- nor delta-opioid receptors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1976234     DOI: 10.1007/bf00178974

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  31 in total

1.  Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse.

Authors:  T J HALEY; W G MCCORMICK
Journal:  Br J Pharmacol Chemother       Date:  1957-03

2.  Opioid delta-receptor involvement in supraspinal and spinal antinociception in mice.

Authors:  J S Heyman; S A Mulvaney; H I Mosberg; F Porreca
Journal:  Brain Res       Date:  1987-09-08       Impact factor: 3.252

3.  The effects of morphine and nalorphine-like drugs in the nondependent, morphine-dependent and cyclazocine-dependent chronic spinal dog.

Authors:  P E Gilbert; W R Martin
Journal:  J Pharmacol Exp Ther       Date:  1976-07       Impact factor: 4.030

4.  Selective antagonists at the opiate delta-receptor.

Authors:  J S Shaw; L Miller; M J Turnbull; J J Gormley; J S Morley
Journal:  Life Sci       Date:  1982 Sep 20-27       Impact factor: 5.037

5.  In vivo evaluation of the opiate delta receptor antagonist ICI 154, 129.

Authors:  J J Gormley; J S Morley; T Priestley; J S Shaw; M J Turnbull; H Wheeler
Journal:  Life Sci       Date:  1982 Sep 20-27       Impact factor: 5.037

6.  The direction of opiodid agonists towards mu-, delta- and epsilon-receptors in the vas deferens of the mouse and the rat.

Authors:  M Wüster; R Schulz; A Herz
Journal:  Life Sci       Date:  1980-07-14       Impact factor: 5.037

7.  In vivo studies with ICI 154,129, a putative delta receptor antagonist.

Authors:  A Cowan; D E Gmerek
Journal:  Life Sci       Date:  1982 Nov 15-22       Impact factor: 5.037

8.  Pharmacological characterization of the epsilon-opiate receptor.

Authors:  R Schulz; M Wüster; A Herz
Journal:  J Pharmacol Exp Ther       Date:  1981-03       Impact factor: 4.030

9.  Evaluation of the interactions of mu and delta selective ligands with [3H]D-Ala2-D-Leu5-enkephalin binding to mouse brain membranes.

Authors:  R W Barrett; J L Vaught
Journal:  Life Sci       Date:  1983-12-12       Impact factor: 5.037

10.  Cyclic somatostatin octapeptide analogues with high affinity and selectivity toward mu opioid receptors.

Authors:  K Gulya; J T Pelton; V J Hruby; H I Yamamura
Journal:  Life Sci       Date:  1986-06-16       Impact factor: 5.037

View more
  6 in total

1.  Effects of intrathecal or intracerebroventricular pretreatment with pertussis toxin on antinociception induced by beta-endorphin or morphine administered intracerebroventricularly in mice.

Authors:  K M Chung; D K Song; H W Suh; M H Lee; Y H Kim
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-06       Impact factor: 3.000

2.  Differential modulation by muscimol and baclofen on antinociception induced by morphine, beta-endorphin, D-Pen2,5-enkephalin and U50,488H administered intracerebroventricularly in the mouse.

Authors:  H W Suh; D K Song; Y H Kim; Y S Choi; J S Yoo; L F Tseng
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-12       Impact factor: 3.000

3.  The antinociception induced by beta-endorphin administered intrathecally is mediated by the activation of mu- and kappa-opioid receptors in the rat.

Authors:  L F Tseng; B Henneberry; K A Collins
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-05       Impact factor: 3.000

4.  Effects of the delta-opioid receptor antagonist naltrindole on antinociceptive responses to selective delta-agonists in post-weanling rats.

Authors:  T J Crook; I Kitchen; R G Hill
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

5.  Characterization of opioid receptors that modulate nociceptive neurotransmission in the trigeminocervical complex.

Authors:  R J Storer; S Akerman; P J Goadsby
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

6.  Repetitive Electroacupuncture Attenuates Cold-Induced Hypertension through Enkephalin in the Rostral Ventral Lateral Medulla.

Authors:  Min Li; Stephanie C Tjen-A-Looi; Zhi-Ling Guo; John C Longhurst
Journal:  Sci Rep       Date:  2016-10-24       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.